Tuberculosis, Pulmonary

Linezolid Dosing Strategies in Drug-Resistant TB

Digital Health Intervention to Improve TPT Uptake

Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis

The LalelaLung Study: Digital Stethoscope Clinical Evaluation

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis

Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients

Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Clinic-based Versus Hotspot-focused Active TB Case Finding

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible Tuberculosis

Shortened Regimen for Drug-susceptible TB in Children

TuBerculosis Viability Interregional Study and Agreement on Biological Tests

Evaluating Urine Isoniazid Testing to Detect Nonadherence to Tuberculosis Medications in India

Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis

Cardiopulmonary Function and Quality of Life in Pulmonary Tuberculosis

Blood Tuberculosis DNA Levels to Monitor Tuberculosis Treatment